Total Valuation
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has a market cap or net worth of €785.06M. The enterprise value is €4.58B.
Market Cap€785.06M
Enterprise Value€4.58B
Share Statistics
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has 336,350,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding336,350,740
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.94%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)5.94%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee871.08K
Profits Per Employee196.08K
Employee Count1,214
Asset Turnover0.30
Inventory Turnover1.58
Valuation Ratios
The current PE Ratio of Zylox-Tonbridge Medical Technology Co., Ltd. Class H is 18.4. Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s PEG ratio is 0.19.
PE Ratio18.4
PS Ratio6.35
PB Ratio2.08
Price to FCF24.98
Price to Operating Cash Flow11.97
PEG Ratio0.19
Income Statement
In the last 12 months, Zylox-Tonbridge Medical Technology Co., Ltd. Class H had revenue of 1.06B and earned 244.37M in profits. Earnings per share was 0.76.
Revenue1.06B
Gross Profit762.92M
Operating Income196.64M
Pretax Income230.61M
Net Income244.37M
EBITDA236.08M
Earnings Per Share (EPS)0.76
Cash Flow
In the last 12 months, operating cash flow was 462.43M and capital expenditures -92.27M, giving a free cash flow of 370.16M billion.
Operating Cash Flow462.43M
Free Cash Flow370.16M
Free Cash Flow per Share1.10
Dividends & Yields
Zylox-Tonbridge Medical Technology Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-16.35%
50-Day Moving Average2.23
200-Day Moving Average2.28
Relative Strength Index (RSI)42.45
Average Volume (3m)1.00
Important Dates
Zylox-Tonbridge Medical Technology Co., Ltd. Class H upcoming earnings date is Mar 25, 2027, TBA (Confirmed).
Last Earnings DateAug 20, 2026
Next Earnings DateMar 25, 2027
Ex-Dividend Date―
Financial Position
Zylox-Tonbridge Medical Technology Co., Ltd. Class H as a current ratio of 5.98, with Debt / Equity ratio of 4.81%
Current Ratio5.98
Quick Ratio5.41
Debt to Market Cap<0.01
Net Debt to EBITDA-2.19
Interest Coverage Ratio197.32
Taxes
In the past 12 months, Zylox-Tonbridge Medical Technology Co., Ltd. Class H has paid -7.43M in taxes.
Income Tax-7.43M
Effective Tax Rate-0.03
Enterprise Valuation
Zylox-Tonbridge Medical Technology Co., Ltd. Class H EV to EBITDA ratio is 26.25, with an EV/FCF ratio of 23.06.
EV to Sales5.86
EV to EBITDA26.25
EV to Free Cash Flow23.06
EV to Operating Cash Flow16.44
Balance Sheet
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has €1.48B in cash and marketable securities with €143.12M in debt, giving a net cash position of €1.34B billion.
Cash & Marketable Securities€1.48B
Total Debt€143.12M
Net Cash€1.34B
Net Cash Per Share€3.98
Tangible Book Value Per Share€9.86
Margins
Gross margin is 73.18%, with operating margin of 18.59%, and net profit margin of 23.11%.
Gross Margin73.18%
Operating Margin18.59%
Pretax Margin21.81%
Net Profit Margin23.11%
EBITDA Margin22.32%
EBIT Margin18.80%
Analyst Forecast
The average price target for Zylox-Tonbridge Medical Technology Co., Ltd. Class H is €3.23, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€3.23
Price Target Upside37.98% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast29.53%
EPS Growth Forecast95.20%